Form4insider filings, from the source

SEC Form 4 · accession 0001231589-26-000019

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul A Mahon
Officer — EVP & GENERAL COUNSEL
Period of report
Sep 3, 2026
Accepted (ET)
Sep 3, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 3, 2026M8,300$146.03A53,472D
Common StockF2Sep 3, 2026S1,545$478.9344D51,927D
Common StockF3Sep 3, 2026S936$479.6575D50,991D
Common StockF4Sep 3, 2026S2,360$480.8613D48,631D
Common StockF5Sep 3, 2026S1,048$481.917D47,583D
Common StockF6Sep 3, 2026S160$482.6625D47,423D
Common StockF7Sep 3, 2026S200$483.8494D47,223D
Common StockF8Sep 3, 2026S954$485.1228D46,269D
Common StockF9Sep 3, 2026S598$486.4682D45,671D
Common StockF10Sep 3, 2026S169$487.3622D45,502D
Common StockSep 3, 2026S10$488.32D45,492D
Common StockSep 3, 2026S320$490.885D45,172D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option$146.03Sep 3, 2026M8,300DMar 15, 2020Mar 15, 2027Common Stock8,30055,840D

Explanation of responses